Atlas Trials

The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)

Clinical trial NCT03140358 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03140358
Sponsor
Singapore National Eye Centre
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Myopia
Start date
2017-04-21
Primary completion
2024-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.